Wells score
Wells Score is a clinical prediction rule used in the diagnosis of pulmonary embolism (PE). It was developed by Dr. Philip Wells and his team in 1998. The Wells Score is a tool that helps physicians determine the likelihood of PE in a patient based on clinical signs and symptoms.
Overview[edit | edit source]
The Wells Score is a scoring system that assigns points to various clinical features and risk factors associated with PE. The total score is then used to categorize patients into different risk groups: low, moderate, or high risk. The higher the score, the greater the likelihood of PE.
Scoring System[edit | edit source]
The Wells Score includes seven criteria, each assigned a certain number of points:
- Clinical signs and symptoms of deep vein thrombosis (DVT) (3 points)
- An alternative diagnosis is less likely than PE (3 points)
- Heart rate over 100 beats per minute (1.5 points)
- Immobilization or surgery in the previous four weeks (1.5 points)
- Previous objectively diagnosed PE or DVT (1.5 points)
- Hemoptysis (1 point)
- Malignancy (1 point)
The total score can range from 0 to 12.5. A score of less than 2 indicates a low probability of PE, a score of 2 to 6 indicates a moderate probability, and a score greater than 6 indicates a high probability.
Clinical Use[edit | edit source]
The Wells Score is used in conjunction with diagnostic testing, such as D-dimer testing and computed tomography pulmonary angiography (CTPA), to diagnose PE. It helps physicians decide which patients require further testing and which can be safely discharged without further workup.
Limitations[edit | edit source]
While the Wells Score is a useful tool, it has some limitations. It is not 100% accurate and should not be used in isolation to rule in or rule out PE. It should always be used in conjunction with other diagnostic tests and clinical judgment.
See Also[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD